Skip to main content

Program Mission

Dr. Kim Kasow’s research interests involve improving outcomes for a pediatric patient who require hematopoietic stem cell transplantation for the possibility of long-term survival. These patients include those requiring autologous and allogeneic stem cell transplants, regardless of the stem cell source.

Our hematopoietic stem cell transplant research team participates in collaborative studies through the following consortiums: the Children’s Oncology Group (COG) , the Blood and Marrow Transplant Clinical Trials Network, and the Pediatric Blood and Marrow Transplant Consortium in order to help move the field of pediatric transplantation forward.

We are active members of the following consortiums offering clinical trials to patients with high-risk, relapsed and refractory malignancies:

Children's Oncology Group  

Program Leaders


Currently Open Clinical Trails – UPDATES COMING SOON!

If you have any questions about our clinical trails, please .


Below is a list of recent publications; for additional publications from Dr. Kasow, please click here.

  1. A trail of unrelated onor marrow transplantation for children with severe sickle cell disease. Shenoy, S., Eapen, M., Panepinto, J.A., Logan, B.R., Wu, J., Abraham, A., Brochstein, J., Chaudhury, S., Godder, K., Haight, A.E., Kasow, K.A., Leung, K., Andreansky, M., Bhatia, M., Dalal, J., Haines, H., Jaroscak, J., Lazarus, H.M., Levine, J.E., Krishnamurti, L., Margolis, D., Megason, G.C., Yu, L.C. Pulsipher, M.A., Gersten, I., DiFronzo, N., Horowitz, M.M., Walters, M.C., & Kamani, N.  (2016). Blood. 
  2. Long-term follow-up after reduced-intensity conditioning and stem cell transplantation for childhood nonmalignant disorders. Madden, L.M., Hayashi, R.J., Chan, K.W., Pulsipher, M.A., Douglas, D., Hale, G.A., Chaudhury, S., Haut, P., Kasow, K.A., Gilman, A.L., Murray, L.M. & Shenoy, S. (2016). Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation.
  3. Sequential renal and bone marrow transplants in a child with Fanconi anemia. Vincent, C.L., Primack, W.A., Hipps, J. & Kasow, K.A. Pediatric Transplantation. 
  4. Using fludarabine to reduce exposure to aklylating agents in children with sickle cell disease receiving busulfan, cyclophosphamide, and antithymocyte globulin transplant conditioning: Results of a dose de-escalation trail. Horan, J.T., Haight, A., Dioguardi, J.L. Brown, C., Grizzle, A., Shelman, C., Kanter, J., Hale, G., Nieder, M., Benton, M, Kasow, K.A., Abraham, A. & Chiang, K.Y. (2015). Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 
  5. Through the eyes of young sibling donors: The hematopoietic stem cell donation experience. D’Auria, J.P, Fitzgerald, T.M, Presler, C.M. & Kasow, K.A. (2015). Journal of Pediatric Nursing.
  6. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Ringden, O., Brazauskas, R., Wang, Z., Ahmed, I., Atsuta, Y., Buchbinder, D., Burns, L.J., Cahn, J.Y., Duncan, C., Hale, G.A., Halter, J., Hayashi, R.J., Hsu, J.W., Jacobsohn, D.A., Kamble, R.T., Kamani, N.R., Kasow, K.A., Khera, N., Lazarus, H.M., Loren, A.W., Marks, D.I., Myers, K.C., Ramanathan, M., Saber, W., Savani, B.N., Schouten, H.C., Socie, G., Sorror, M.L., Steinberg, A., Popat, U., Wingard, J.R., Mattsson, J. & Majhail, N.S. (2014). Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation.

Return to Top